Download Free Sample Report

The global Injected Veterinary Pain Management Drugs market size was valued at US$ 1.23 billion in 2024 and is projected to reach US$ 1.78 billion by 2030, at a CAGR of 6.4% during the forecast period 2024-2030.

United States Injected Veterinary Pain Management Drugs market size was valued at US$ 456 million in 2024 and is projected to reach US$ 634 million by 2030, at a CAGR of 5.6% during the forecast period 2024-2030.

The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Opioids Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Injected Veterinary Pain Management Drugs include Boehringer Ingelheim, Merck & Co, Zoetis, Elanco, Bayer Pharma AG, Ceva Sante Animale, Norbrook Laboratories, Baxter and Halyard, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Injected Veterinary Pain Management Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injected Veterinary Pain Management Drugs. This report contains market size and forecasts of Injected Veterinary Pain Management Drugs in global, including the following market information:

• Global Injected Veterinary Pain Management Drugs Market Revenue, 2019-2024, 2025-2030, ($ millions)
• Global Injected Veterinary Pain Management Drugs Market Sales, 2019-2024, 2025-2030, (K Units)
• Global top five Injected Veterinary Pain Management Drugs companies in 2023 (%)

We has surveyed the Injected Veterinary Pain Management Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injected Veterinary Pain Management Drugs Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Injected Veterinary Pain Management Drugs Market Segment Percentages, by Type, 2023 (%)

• Opioids
• 2-Adrenergic Agonists
• Local Anesthetics
• Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
• Sedatives
• Other

Global Injected Veterinary Pain Management Drugs Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Injected Veterinary Pain Management Drugs Market Segment Percentages, by Application, 2023 (%)

• Veterinary Hospitals
• Veterinary Clinics
• For Retail
• Others

Global Injected Veterinary Pain Management Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Injected Veterinary Pain Management Drugs Market Segment Percentages, By Region and Country, 2023 (%)

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Injected Veterinary Pain Management Drugs revenues in global market, 2019-2024 (Estimated), ($ millions)
• Key companies Injected Veterinary Pain Management Drugs revenues share in global market, 2023 (%)
• Key companies Injected Veterinary Pain Management Drugs sales in global market, 2019-2024 (Estimated), (K Units)
• Key companies Injected Veterinary Pain Management Drugs sales share in global market, 2023 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Boehringer Ingelheim
• Merck & Co
• Zoetis
• Elanco
• Bayer Pharma AG
• Ceva Sante Animale
• Norbrook Laboratories
• Baxter
• Halyard
• Bostonscientific
• Lilly
• Endo International
• Forest Laboratories
• Medtronic
• Including or Excluding key companies relevant to your analysis.

Outline of Major Chapters:
Chapter 1: Introduces the definition of Injected Veterinary Pain Management Drugs, market overview.
Chapter 2: Global Injected Veterinary Pain Management Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Injected Veterinary Pain Management Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Injected Veterinary Pain Management Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Injected Veterinary Pain Management Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.